We read with great interest the article “Respiratory depression after spinal single-shot caesarean section with 100 μg morphine” by Hiroki Onodera and colleagues [1] on monitoring bradypnea after cesarean section performed with 0.1 mg intrathecal morphine. The authors performed spinal anesthesia with 2–2.5 ml hyperbaric bupivacaine (0.5%) + 10 µg fentanyl + 100 µg morphine, additional seda- tion and analgesia at the discretion of the anesthesiologist, and for postoperative pain management, patients received acetaminophen 1 g IV every 6 h, while flurbiprofen and/or opioid drug and pentazocine, at the discretion of the obstetri- cian. The authors observed episodes of sustained bradypnea in approximately half of women in their study and found a low rate of cumulative bradypnea time with no related factors. Despite these results, the authors concluded that: “respiratory monitoring may not be necessary as patients undergoing cesarean delivery are generally young, healthy women”

Biava, A.m., Cipriani, G., Bilotta, F. (2023). Is opioid-free analgesia the first tier choice in anesthesia for cesarean delivery?. JOURNAL OF ANESTHESIA, 492-493 [10.1007/s00540-023-03184-6].

Is opioid-free analgesia the first tier choice in anesthesia for cesarean delivery?

Bilotta, F
2023-01-01

Abstract

We read with great interest the article “Respiratory depression after spinal single-shot caesarean section with 100 μg morphine” by Hiroki Onodera and colleagues [1] on monitoring bradypnea after cesarean section performed with 0.1 mg intrathecal morphine. The authors performed spinal anesthesia with 2–2.5 ml hyperbaric bupivacaine (0.5%) + 10 µg fentanyl + 100 µg morphine, additional seda- tion and analgesia at the discretion of the anesthesiologist, and for postoperative pain management, patients received acetaminophen 1 g IV every 6 h, while flurbiprofen and/or opioid drug and pentazocine, at the discretion of the obstetri- cian. The authors observed episodes of sustained bradypnea in approximately half of women in their study and found a low rate of cumulative bradypnea time with no related factors. Despite these results, the authors concluded that: “respiratory monitoring may not be necessary as patients undergoing cesarean delivery are generally young, healthy women”
2023
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MEDS-23/A - Anestesiologia
English
Cesarean delivery;
Obstetric anesthesia;
Opioid-free analgesia;
Opioids in obstetric patient
Biava, A.m., Cipriani, G., Bilotta, F. (2023). Is opioid-free analgesia the first tier choice in anesthesia for cesarean delivery?. JOURNAL OF ANESTHESIA, 492-493 [10.1007/s00540-023-03184-6].
Biava, Am; Cipriani, G; Bilotta, F
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
2023 OpFreeAn-JA23.pdf

solo utenti autorizzati

Tipologia: Versione Editoriale (PDF)
Licenza: Copyright dell'editore
Dimensione 273.85 kB
Formato Adobe PDF
273.85 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/462214
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 5
social impact